These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15131329)

  • 1. Modeling diabetic sensory neuropathy in rats.
    Calcutt NA
    Methods Mol Med; 2004; 99():55-65. PubMed ID: 15131329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tactile allodynia and formalin hyperalgesia in streptozotocin-diabetic rats: effects of insulin, aldose reductase inhibition and lidocaine.
    Calcutt NA; Jorge MC; Yaksh TL; Chaplan SR
    Pain; 1996 Dec; 68(2-3):293-9. PubMed ID: 9121817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of sensory function and antihyperalgesic properties of a prosaposin-derived peptide in diabetic rats.
    Calcutt NA; Freshwater JD; O'Brien JS
    Anesthesiology; 2000 Nov; 93(5):1271-8. PubMed ID: 11046216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterization of different fractions of Calotropis procera (Asclepiadaceae) in streptozotocin induced experimental model of diabetic neuropathy.
    Yadav SK; Nagori BP; Desai PK
    J Ethnopharmacol; 2014 Mar; 152(2):349-57. PubMed ID: 24486599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orofacial sensory changes after streptozotocin-induced diabetes in rats.
    Nones CF; Reis RC; Jesus CH; Veronez DA; Cunha JM; Chichorro JG
    Brain Res; 2013 Mar; 1501():56-67. PubMed ID: 23313875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinociceptive action of a p38alpha MAPK inhibitor, SD-282, in a diabetic neuropathy model.
    Sweitzer SM; Medicherla S; Almirez R; Dugar S; Chakravarty S; Shumilla JA; Yeomans DC; Protter AA
    Pain; 2004 Jun; 109(3):409-419. PubMed ID: 15157702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Animal models of painful diabetic neuropathy: the STZ rat model.
    Morrow TJ
    Curr Protoc Neurosci; 2004 Nov; Chapter 9():Unit 9.18. PubMed ID: 18428614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factor.
    Calcutt NA; Freshwater JD; Mizisin AP
    Diabetologia; 2004 Apr; 47(4):718-24. PubMed ID: 15298349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of primary afferent nerves in allodynia caused by diabetic neuropathy in rats.
    Khan GM; Chen SR; Pan HL
    Neuroscience; 2002; 114(2):291-9. PubMed ID: 12204199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fosinopril Prevents the Development of Tactile Allodynia in a Streptozotocin-Induced Diabetic Rat Model.
    Araiza-Saldaña CI; Pedraza-Priego EF; Torres-López JE; Rocha-González HI; Castañeda-Corral G; Hong-Chong E; Granados-Soto V
    Drug Dev Res; 2015 Dec; 76(8):442-9. PubMed ID: 26349482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of low-dose insulin on mechanical sensitivity and allodynia in type I diabetes neuropathy.
    Hoybergs YM; Meert TF
    Neurosci Lett; 2007 May; 417(2):149-54. PubMed ID: 17412508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific antinociceptive activity of cholest-4-en-3-one, oxime (TRO19622) in experimental models of painful diabetic and chemotherapy-induced neuropathy.
    Bordet T; Buisson B; Michaud M; Abitbol JL; Marchand F; Grist J; Andriambeloson E; Malcangio M; Pruss RM
    J Pharmacol Exp Ther; 2008 Aug; 326(2):623-32. PubMed ID: 18492948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stable Rat Model of Mechanical Allodynia in Diabetic Peripheral Neuropathy: The Role of Nerve Compression.
    Liao C; Yang M; Liu P; Zhong W; Zhang W
    J Reconstr Microsurg; 2018 May; 34(4):264-269. PubMed ID: 29396983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Luteolin improves the impaired nerve functions in diabetic neuropathy: behavioral and biochemical evidences.
    Li M; Li Q; Zhao Q; Zhang J; Lin J
    Int J Clin Exp Pathol; 2015; 8(9):10112-20. PubMed ID: 26617718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial respiratory chain dysfunction in dorsal root ganglia of streptozotocin-induced diabetic rats and its correction by insulin treatment.
    Chowdhury SK; Zherebitskaya E; Smith DR; Akude E; Chattopadhyay S; Jolivalt CG; Calcutt NA; Fernyhough P
    Diabetes; 2010 Apr; 59(4):1082-91. PubMed ID: 20103706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxcarbazepine antinociception in animals with inflammatory pain or painful diabetic neuropathy.
    Kiguchi S; Imamura T; Ichikawa K; Kojima M
    Clin Exp Pharmacol Physiol; 2004; 31(1-2):57-64. PubMed ID: 14756685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired formalin-evoked changes of spinal amino acid levels in diabetic rats.
    Malmberg AB; O'Connor WT; Glennon JC; Ceseña R; Calcutt NA
    Brain Res; 2006 Oct; 1115(1):48-53. PubMed ID: 16920081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An adenosine kinase inhibitor attenuates tactile allodynia in a rat model of diabetic neuropathic pain.
    Lynch JJ; Jarvis MF; Kowaluk EA
    Eur J Pharmacol; 1999 Jan; 364(2-3):141-6. PubMed ID: 9932716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance occurs in parallel with sensory neuropathy in streptozotocin-induced diabetes in rats: differential response to early vs late insulin supplementation.
    Szilvássy Z; Németh J; Kovács P; Paragh G; Sári R; Vígh L; Peitl B
    Metabolism; 2012 Jun; 61(6):776-86. PubMed ID: 22154324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of resveratrol on nerve functions, oxidative stress and DNA fragmentation in experimental diabetic neuropathy.
    Kumar A; Kaundal RK; Iyer S; Sharma SS
    Life Sci; 2007 Mar; 80(13):1236-44. PubMed ID: 17289084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.